Analyze Diet
Biochimica et biophysica acta1979; 567(1); 161-173; doi: 10.1016/0005-2744(79)90183-9

A mechanistic model for butyrylcholinesterase.

Abstract: A plausible mechanism of action of horse serum butyrylcholinesterase is proposed. It includes substrate activation at the level of deacylation. The rate constant for the acylation of the enzyme appears to be much greater than the rate constant for the deacylation, at low substate concentrations. At higher substrate concentrations the rate constants become more similar. No interaction between the four subunits in binding of inhibitors or in the catalysis was observed. There is one esteratic and one anionic site per subunit apparent from labelling studies with [32P]diisopropylfluorophosphate and binding studies with N-methylacridine. Although the tetrametric form of the enzyme appears to be the native one, the monomeric and several other aggregated and dissociated states are catalytically active.
Publication Date: 1979-03-16 PubMed ID: 454620DOI: 10.1016/0005-2744(79)90183-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research proposes a plausible action mechanism for horse serum butyrylcholinesterase, suggesting that substrate activation occurs at the deacylation level, with rate constants for acylation being greater than deacylation at low concentrations, and relatively similar at higher ones. It also suggests no interaction between the enzyme’s subunits, with each having one esteratic and one anionic site.

Mechanistic Model for Butyrylcholinesterase

To present a clear picture of the article, the findings of this research can be simplified as follows:

  • The research suggests a plausible mechanism of action for butyrylcholinesterase, an important enzyme present in the serum of horses. The model primarily suggests the substrate (material or substance on which an enzyme acts) activation occurring at the deacylation level.
  • Deacylation refers to the process of removing an acyl group. The acyl group is commonly observed in organic compounds. Its presence influences the characteristics and properties of compounds. By suggesting that the substrate activation happens at the deacylation level, the researchers observe that the removal of the acyl group plays a crucial role in how butyrylcholine functions.

Rate Constants at Different Concentrations

  • The rate constants, which are the factors determining the speed at which reactions occur, are discussed within the context of different substrate concentrations. The research shows that the rate constant for the acylation (adding an acyl group) of the enzyme is much greater than the rate constant for deacylation when the substrate concentrations are low.
  • However, at higher substrate concentrations, these rate constants start to become more similar. This suggests that the rate at which these reactions occur (acylation and deacylation), and hence the functionality of the enzyme, depends on the concentration of the substrate.

No Interaction Between Subunits

  • Furthermore, the research explains that they did not observe any interaction between the four subunits in enzyme binding of inhibitors or in the catalysis (acceleration of a chemical reaction). This implies that each subunit operates independently in these processes.
  • The study also discovered that each of these subunits seems to have one esteratic (relating to esters) and one anionic (negative ion) site, which were deduced from labeling studies using [32P]diisopropylfluorophosphate and binding studies with N-methylacridine.

Catalytic Variations in Different States

  • Finally, the researchers note that the enzyme exists in different states, the monomeric, tetratomic and other aggregated and dissociated states. The tetratomic form of the enzyme was noted to be the native one.
  • Most importantly, despite the different forms the enzyme might take, it maintains its catalytic activity. This suggests a great degree of versatility and stability on the part of the enzyme, as it continues to function in various states.

Cite This Article

APA
Eriksson H, Augustinsson KB. (1979). A mechanistic model for butyrylcholinesterase. Biochim Biophys Acta, 567(1), 161-173. https://doi.org/10.1016/0005-2744(79)90183-9

Publication

ISSN: 0006-3002
NlmUniqueID: 0217513
Country: Netherlands
Language: English
Volume: 567
Issue: 1
Pages: 161-173

Researcher Affiliations

Eriksson, H
    Augustinsson, K B

      MeSH Terms

      • Acylation
      • Animals
      • Binding Sites
      • Binding, Competitive
      • Butyrylcholinesterase / metabolism
      • Choline / pharmacology
      • Cholinesterase Inhibitors
      • Cholinesterases / metabolism
      • Horses
      • Isoflurophate
      • Kinetics
      • Models, Chemical
      • Temperature

      Citations

      This article has been cited 6 times.
      1. Chen X, Fang L, Liu J, Zhan CG. Reaction pathway and free energy profiles for butyrylcholinesterase-catalyzed hydrolysis of acetylthiocholine.. Biochemistry 2012 Feb 14;51(6):1297-305.
        doi: 10.1021/bi201786spubmed: 22304234google scholar: lookup
      2. Darvesh S, Walsh R, Martin E. Homocysteine thiolactone and human cholinesterases.. Cell Mol Neurobiol 2007 Feb;27(1):33-48.
        doi: 10.1007/s10571-006-9114-0pubmed: 16955366google scholar: lookup
      3. Colletier JP, Fournier D, Greenblatt HM, Stojan J, Sussman JL, Zaccai G, Silman I, Weik M. Structural insights into substrate traffic and inhibition in acetylcholinesterase.. EMBO J 2006 Jun 21;25(12):2746-56.
        doi: 10.1038/sj.emboj.7601175pubmed: 16763558google scholar: lookup
      4. Botti SA, Felder CE, Lifson S, Sussman JL, Silman I. A modular treatment of molecular traffic through the active site of cholinesterase.. Biophys J 1999 Nov;77(5):2430-50.
        doi: 10.1016/S0006-3495(99)77080-3pubmed: 10545346google scholar: lookup
      5. Marcel V, Palacios LG, Pertuy C, Masson P, Fournier D. Two invertebrate acetylcholinesterases show activation followed by inhibition with substrate concentration.. Biochem J 1998 Jan 15;329 ( Pt 2)(Pt 2):329-34.
        doi: 10.1042/bj3290329pubmed: 9425116google scholar: lookup
      6. Masson P, Froment MT, Bartels CF, Lockridge O. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.. Biochem J 1997 Jul 1;325 ( Pt 1)(Pt 1):53-61.
        doi: 10.1042/bj3250053pubmed: 9224629google scholar: lookup